BDBM385512 (R or S)-4-((R or S)-1- (2-chloro-6-(1- (difluoromethyl)cyclo- propyl)benzoyl)-6-(3- methoxyazetidine-1- carbonyl)-4,5,6,7- tetrahydro-1H-indazol-3- yl)-1-methylcyclohex-3- ene-1-carboxylic acid::US10287272, Example 7D::US10287272, Example 8D::US10689369, Example 8D

SMILES COC1CN(C1)C(=O)C1CCc2c(C1)n(nc2C1=CCC(C)(CC1)C(O)=O)C(=O)c1c(Cl)cccc1C1(CC1)C(F)F

InChI Key InChIKey=UYKNWUYMCKKENK-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 385512   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM385512(US10287272, Example 8D | (R or S)-4-((R or S)-1- (...)
Affinity DataIC50: 1nMAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM385512(US10287272, Example 8D | (R or S)-4-((R or S)-1- (...)
Affinity DataIC50: 1nMAssay Description:To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM385512(US10287272, Example 8D | (R or S)-4-((R or S)-1- (...)
Affinity DataIC50: 1nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM385512(US10287272, Example 8D | (R or S)-4-((R or S)-1- (...)
Affinity DataIC50: 1nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details
Go to US Patent